Evaluation of pteridine metabolism in battery workers chronically exposed to lead

Human and Experimental Toxicology

Volumn 25, Issue 7, 2006, Pages 353-359

  Engin, A B ^a   Tuzun, D ^b   Sahin, Gonul ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b ANKARA OCCUPATIONAL DISEASES HOSPITAL   (Turkey)

Author keywords

Battery workers; Biopterin; Dihydropteridine reductase; Lead; Neopterin

Indexed keywords

AMINOLEVULINIC ACID; BIOPTERIN; CREATININE; DIHYDROPTERIDINE REDUCTASE; LEAD; NEOPTERIN; NEUROTRANSMITTER; PTERIDINE;

ADULT; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BATTERY INDUSTRY; CHRONIC TOXICITY; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LEAD BLOOD LEVEL; LEAD POISONING; LOCOMOTION; MALE; MUSCLE WEAKNESS; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; SPECTROPHOTOMETRY;

ADULT; AIR POLLUTANTS, OCCUPATIONAL; AMINOLEVULINIC ACID; BIOLOGICAL MARKERS; BIOPTERIN; CREATININE; DIHYDROPTERIDINE REDUCTASE; ENVIRONMENTAL MONITORING; EVALUATION STUDIES; HUMANS; LEAD; MALE; NEOPTERIN; NEUROMUSCULAR JUNCTION DISEASES; OCCUPATIONAL EXPOSURE; PTERIDINES;

EID: 33746478150     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1191/0960327106ht634oa     Document Type: Article

References (38)

1. Apostoli P. Update on the subject of lead toxicology. Ann Ist Super Sanita 1998; 34: 5-15.
2. Araki S, Sato H, Yokoyama K, Murata K. Subclinical neurophysiological effects of lead: a review on peripheral, central, and autonomic nervous system effects in lead workers. Am J Ind Med 2000; 37: 193-204.
3. Sanin LH, Gonzalez-Cossio T, Romieu I, Hernandez-Avila M. Accumulation of lead in bone and its effects on health. Salud Publ Mexico 1998; 40: 359-68.
4. Hu H, Rabinowitz M, Smith D. Bone lead as a biological marker in epidemiologic studies of chronic toxicity: conceptual paradigms. Environ Health Perspect 1998; 106: 1-8.
5. Hu H, Watanabe H, Payton M, Korrick S, Rotnitzky A. The relationship between bone lead and hemoglobin. J Am Med Assoc 1994; 272: 1512-17.
6. Ghorbe F, Boujelbene M, Makni-Ayadi F, Guermazi F, Kammoun A, Murat J, et al. Effect of chronic lead exposure on kidney function in male and female rats: determination of a lead exposure biomarker. Arch Physiol Biochem 2001; 109: 457-63.
7. Hasan MY, Alshuaib WB, Singh S, Fahim MA. Effects of ascorbic acid on lead induced alterations of synaptic transmission and contractile features in murine dorsiflexor muscle. Life Sci 2003; 73: 1017-25.
8. Nehru B, Sidhu P. Behavior and neurotoxic consequences of lead on rat brain followed by recovery. Biol Trace Elem Res 2001; 84: 113-21.
9. Cutler P, Blair JA. The effect of lead and aluminium on rat dihydropteridine reductase. Arch Toxicol 1987; Suppl 11: 227-30.
10. Firgaira FA, Cotton RGH, Danks DM. Dihydropteridine reductase deficiency diagnosis by assays on peripheral blood cells. Lancet 1976; 2: 1260-63.
11. Homan CS, Brogan GX, Orava RS. Lead toxicity. Viccellio P ed. Emergency toxicology. Lippincott-Raven, 1998.
12. Martinez-Fong D, Gutierrez ME, Aceves J. Effect of chronic lead exposure on biopterin metabolism in the rat neostriatum. J Neurosci Res 1990; 26: 112-14.
13. Church HJ, Day JP, Braithwaite RA, Brown SS. Binding of lead to a metallothionein-like protein in human erythrocytes. J Inorg Biochem 1993; 49: 55-68.
14. Goyer RA. Lead toxicity: current concerns. Environ Health Persp 1993; 100: 177-87.
15. Sulkowski G, Dabrowska-Bouta B, Waskiewicz J, Rafalowska U. Inhibition of dopamine transport and binding of [3H] spiperone to dopamine D2 receptor by acute Pb-toxicity in vivo. Folia Neuropathol 1999; 37: 205-209.
16. Bailey CC, Kitchen I. Ontogeny of catecholamine and GABA levels in rat brain: lack of effect of perinatal lead exposure. Toxicol Lett 1986; 30: 97-102.
17. Krocova Z, Macela A, Kroca M, Hernychova L. The immunomodulatory effect(s) of lead and cadmium on the cells of immune system in vitro. Toxicol In Vitro 2000; 14: 33-40.
18. Mauel J, Ransijn A, Buchmuller-Rouiller Y. Lead inhibits intracellular killing of Leishmania parasites and extracellular cytolysis of target cells by macrophages exposed to macrophage activating factor. J Leukoc Biol 1989; 45: 401-409.
19. Wachter H, Fuchs D, Hausen A, Reibnegger G, Weiss G, Werner ER, et al. Neopterin, biochemistry, methods, clinical application. Walter de Gruyter, 1992.
20. Stark J. Interpretation of BUN and serum creatinine. An interactive exercise. Crit Care Nurs North Am 1998; 10: 491-96.
21. Jurodo R, Mattix H. The decrease serum urea nitrogen-creatinine ratio. Arch Intern Med 1998; 158: 2509-11.
22. Henry RM, Kamp O, Kostense PJ, Spijkerman AM, Dekker JM, Nijpels G, et al. Mild renal insufficiency is associated with increased left ventricular mass in men, but not in women: an arterial stiffness-related phenomenon - the Hoorn Study. Kidney Int 2005; 68: 673-79.
23. Artunc FH, Fischer IU, Risler T, Erley CM. Improved estimation of GFR by serum cystatin C in patients undergoing cardiac catheterization. Int J Cardiol 2005; 102: 173-78.
24. Kaplan LA, Pesce AJ. Clinical chemistry theory, analysis, correlation, third edition. Missouri, 1996.
25. Ambrose TM, Al-Lozi M, Scott MG. Bone lead concentrations assessed by in vivo X-ray fluorescence. Clin Chem 2000; 46: 1171-78.
26. Sanchez S, Perez Aguilar R, Genta S, Aybar M, Villecco E, Sanchez Riera A. Renal extracellular matrix alterations in lead-treated rats. J Appl Toxicol 2001; 21: 417-23.
27. Choi HJ, Kim SW, Lee SY, Hwang O. Dopamine-dependent cytotoxicity of tetrahydrobiopterin: a possible mechanism for selective neurodegeneration in Parkinson's disease. J Neurochem 2003; 86: 143-52.
28. Jablonska L, Walski M, Rafalowska U. Lead as an inductor of some morphological and functional changes in synaptosomes from rat brain. Cell Mol Neurobiol 1994; 14: 701-709.
29. Minnema DJ, Michaelson IA. Differential effects of inorganic lead and delta-aminolevulinic acid in vitro on synaptosomal gamma-aminobutyric acid release. Toxicol Appl Pharmacol 1986; 86: 437-47.
30. Kumar P, Husain SG, Murthy RC, Srivastava SP, Anand M, Ali MM, et al. Neuropsychological studies on lead battery workers. Vet Hum Toxicol 2002; 4: 76-78.
31. Gurer H, Ozgunes H, Neal R, Spitz DR, Ercal N. Antioxidant effects of N-acetylcysteine and succimer in red blood cells from lead-exposed rats. Toxicology 1998; 128: 181-89.
32. Tandon SK, Singh S, Prasad S, Srivastava S, Siddiqui MK. Reversal of lead-induced oxidative stress by chelating agent, antioxidant, or their combination in the rat. Environ Res 2002; 90: 61-66.
33. Costa CA, Trivelato GC, Pinto AM, Bechara. Correlation between plasma 5-aminolevalunic acid concentrations and indicators of oxidative stress in lead-exposed workers. Clin Chem 1997; 43: 1196-202.
34. Loghman-Adham M. Renal effects of environmental and occupational lead exposure. Environ Health Perspect 1997; 105: 928-39.
35. Cake KM, Bowins RJ, Vaillancourt C, Gordon CL, McNutt RH, Laporte R, et al. Partition of circulating lead between serum and red cells is different for internal and external sources of lead. Am J Ind Med 1996; 29: 440-45.
36. Nilsson U, Attewell R, Christoffersson JO, Schutz A, Ahlgren L, Skerfving S, et al. Kinetics of lead in bone and blood after end of occupational exposure. Pharmacol Toxicol 1991; 69: 477-84.
37. Hu H, Aro A, Rotnitzky A. Bone lead measured by X-ray fluorescence: epidemiologic methods. Environ Health Perspect 1995; 103: 105-10.
38. Todd AC, Wetmur JG, Moline JM, Godbold JH, Levin SM, Landrigan PJ. Unraveling the chronic toxicity of lead: an essential priority for environmental health. Environ Health Perspect 1996; 104: 141-46.